DEMMUNIZATION
Dead / Abandoned — Abandoned — failure to respond (as of 18 Oct 2022)
What this means for you
This application is over — abandoned 07 Oct 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90818079
- Mark type
- Stylized text
- Filed
- 08 Jul 2021
- Abandoned
- 07 Oct 2022
- Attorney of record
- Roy D. Gross
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases and disorders; Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases by eliminating specific lymphocytes lineages or modulating the immune response using a variety of organic compounds and recombinant proteins; Pharmaceutical preparations and substances that modulate the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the antibody creation and antigen specific immune response in autoimmune, Allergic and inflammatory diseases; Pharmaceutical preparations and substances that modulate the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the creation of the antibodies IgG, IgE or IgA and antigen specific immune response in autoimmune, allergic and inflammatory diseases; Pharmaceutical preparations and substances with potential immunomodulation activity to treat under and over responsiveness of the immune system
Owner
- CANOPY IMMUNO-THERAPEUTICS LTD., Magadim, IL
Prosecution history
- 18 Oct 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 18 Oct 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 06 Apr 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Apr 2022 — NON-FINAL ACTION E-MAILED
- 06 Apr 2022 — NON-FINAL ACTION WRITTEN
- 28 Mar 2022 — ASSIGNED TO EXAMINER
- 15 Sept 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Jul 2021 — NEW APPLICATION ENTERED